Tirzepatide is a large protein molecule , and large protein molecules generally do not pass easily into breast milk
TRIUMPH-4 (Phase 3, 68 weeks) 12mg dose: 28.7% weight loss (~71 lbs / 32 kg average) 9mg dose: 26.4% weight loss (~64 lbs / 29 kg average) Patients also saw 76% reduction in knee osteoarthritis pain Blood pressure reduced by 14 mmHg on average Source: ClinicalTrials.gov (TRIUMPH-4, NCT05931367) The TRIUMPH Phase 3 program includes 4 trials studying retatrutide for obesity, type 2 diabetes, and cardiovascular outcomes
Ozempic (semaglutide for T2D) If you have type 2 diabetes, Ozempic (semaglutide) is broadly covered for T2D with PA across most plans regardless of whether the employer opted into anti-obesity coverage
How Affiliate Reviewers Rate BehemothLabz Across multiple review platforms, research-focused content publishers and affiliate evaluators consistently rank Behemoth Labz GLP-1 Nasal Spray among the top experimental tools in the peptide-driven metabolic support category
You can also browse top-drug categories to see commonly preferred and non-preferred options
Potential Side Effects and Limited Long-Term Safety Data Potential side effects and limited long-term safety data are restraining the growth of the GLP-1 targeted peptide weight loss drugs market
